BRIAN BRINEGAR: Open Payments
NPI 1821181751 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,149 in 168 payments from 25 companies in 2025. Trend: 2023 $12,040 · 2024 $9,498 · 2025 $6,149
Food & beverage: $3,449Speaker / faculty: $1,440Consulting: $1,260
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $1,683 |
| UCB, Inc. | 11 | $1,068 |
| Journey Medical Corporation | 2 | $513 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $418 |
| Novartis Pharmaceuticals Corporation | 16 | $371 |
| Galderma Laboratories, L.P. | 14 | $301 |
| ABBVIE INC. | 14 | $248 |
| Janssen Biotech, Inc. | 15 | $240 |
| Organon LLC | 11 | $239 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $164 |
Products named: CIBINQO, Bimzelx, TREMFYA, NEMLUVIO, COSENTYX, SKYRIZI, VTAMA, ILUMYA.
Industry payments across AZ — which companies pay providers there.
